Today’s Forbes Daily newsletter features a reprieve on weight loss drug prices, over 1 million jobs cut, holiday shopping expectations, Mark Zuckerberg’s drop and more.
ByDanielle Chemtob,
Forbes Staff
andForbes Daily,
Forbes Staff.
Americans will soon get a reprieve on the sky-high cost of some weight loss drugs thanks to a deal President Donald Trump announced Thursday.
Here's how much weight loss drugs could cost you under Trump's deals with Eli Lilly, Novo Nordisk
Musk's $1 trillion pay, a price cut for obesity drugs, Target's in-store woes and more in Morning Squawk
Trump unveils deals to lower US weight-loss drug prices
US to slash prices of obesity drugs offered on Trump website
Trump announces deals with Eli Lilly, Novo Nordisk to slash weight loss drug prices, offer some Medicare coverage
Weight-loss drug makers announce pricing agreement with Trump
Trump punches new $35 billion hole in national debt with deal for Medicare to cover your Ozempic | Fortune
Pfizer beats out Novo Nordisk in bidding for obesity drugmaker Metsera | Fortune
Millions more Americans could access obesity drugs after Trump's deals with Eli Lilly, Novo Nordisk
Elon Musk’s $1 trillion pay package was the result of a race to the bottom among states with weak corporate governance laws | Fortune
Today’s Forbes Daily newsletter covers how health care is buoying the job market, Supreme Court hears birthright citizenship…
The monthly out-of-pocket cost of popular injections and upcoming pills could range from $50 to $350, depending on the dosage and…
Here are five key things investors need to know to start the trading day.
The deal also means Medicare will start covering obesity drugs for some patients for the first time beginning next year.
US President Donald Trump announces agreements with drug makers Eli Lilly and Novo Nordisk.
The pharmaceutical giant and Novo Nordisk said they would lower the prices of their popular weight loss drugs to expand access.
